Ittai Harel is a Managing General Partner with Pitango Venture Capital. His investment focus is in Healthcare, and includes digital health, medical devices, diagnostics, and specialty pharma.
Before joining Pitango, Ittai headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals. He also served as head of business development at IDEXX Laboratories (NASDAQ: IDXX).
Ittai currently serves on the Board of directors of DouxMatok, Intensix, Inotek Pharmaceuticals (NASDAQ: ITEK), LifeBond, EarlySense, Medisafe, Valeritas, Vertos Medical, Tscan and Click Therapeutics and serves as Chairman of the Board at LifeBond and EarlySense
Ittai holds a B.Sc. in Chemical Engineering and Biotechnology from Ben Gurion University, and an MBA from the MIT Sloan School of Management.